Filing metadata

Accession number
0001213900-22-080137
Form type
Form 3
Filer
Immune Therapeutics, Inc.
CIK
CIK 1559356
Filed
Dec 15, 2022
Reporting period
Jul 25, 2022
Description
Initial ownership

Explore SEC Filings Hub